eli lilly and company retatrutide Inside the grey market for Retatrutide, Lilly’s newest GLP drug 💉, Eli Lilly Expands Into Infectious

10.1007/s00296-011-1874-2 27 LiuY.YuX.ZhangW.ZhangX.WangM.JiF

Patient healed quickly with no complications and maintained her results easily

The long-term safety of GLP-1s is still being established, but emerging research has begun to highlight several areas of concern

For patients who are near their ideal weight but have stubborn fat pockets, adding body sculpting to the plan can address areas that diet and exercise alone cannot fix

[1] [2] Common GLP-1 medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist

Matching accounted for demographics, body mass index (BMI), hemoglobin A1c, and multiple comorbidities